Viewing Study NCT02527434


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-06-09 @ 9:24 PM
Study NCT ID: NCT02527434
Status: COMPLETED
Last Update Posted: 2023-11-15
First Post: 2015-08-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Tremelimumab in Patients With Advanced Solid Tumors
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Bladder Cancer View
None Triple-negative Breast Cancer View
None Pancreatic Ductal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced … View